The haemophilia A treatment emicizumab (Hemlibra) will be available from 2 November via national blood supply arrangements for use at home under the supervision of a Haemophilia Treatment Centre. As previously announced, the product will be available “to prevent or reduce the frequency of bleeding in severe or moderate haemophilia A patients without inhibitors, and ...
Hemlibra now available for self injection at home
By Michael Woodhead
16 Nov 2020